Deutsche Bank downgraded Pharmacyclics (NASDAQ: PCYC) from Buy to Hold with a price target of $235 (from $205). The change ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE